A Window of Opportunity Study of Black Raspberry for Patients With HNSCC

Summary

The purpose of this phase 0 Window of Opportunity study is to have subjects with Head and Neck Squamous Cell Carcinoma (HNSCC) receive same dosage of Black Raspberry Extract between their cancer diagnosis and standard treatment (surgery). Tumor biopsies and research blood before and after the investigational treatment (Black Raspberry Extract lozenges) are collected for translational research. The investigational treatment is kept short to avoid delaying standard treatment.

Timeline

Start

2025-06-01

Primary completion

2027-06-01

Completion

2027-12-01

Outcome

Outcome not reported

Stopped (Business): “The study was not initiated due to funding constraints and will not proceed in its current design.”

Drugs

Indications